Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines 
resistant to anti-HER-2 antibodies

van der Horst, E. H.; Murgia, M.; Treder, M.; Ullrich, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies

MPS-Authors

/persons/resource/persons78812

Ullrich, A.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

van der Horst, E. H., Murgia, M., Treder, M., & Ullrich, A. (2005). Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies. International Journal of Cancer, 115(4), 519-527.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-65D9-E

Abstract

There is no abstract available